- Report
- March 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- March 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- February 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- December 2025
- 150 Pages
United States
From €4345EUR$4,950USD£3,780GBP
- Report
- January 2026
- 100 Pages
Africa
From €4169EUR$4,750USD£3,627GBP
- Report
- January 2026
- 126 Pages
Europe
From €4169EUR$4,750USD£3,627GBP
- Report
- February 2025
- 80 Pages
Europe
From €3511EUR$4,000USD£3,055GBP
- Report
- November 2025
- 101 Pages
Europe
From €3467EUR$3,950USD£3,017GBP
- Report
- November 2025
- 75 Pages
Africa, Middle East
From €3028EUR$3,450USD£2,635GBP
- Report
- November 2025
- 89 Pages
North America
From €3028EUR$3,450USD£2,635GBP
- Report
- July 2025
- 81 Pages
Africa, Middle East
From €3028EUR$3,450USD£2,635GBP
- Report
- May 2025
- 89 Pages
North America
From €2589EUR$2,950USD£2,253GBP
- Report
- March 2025
- 78 Pages
North America
From €2589EUR$2,950USD£2,253GBP
- Report
- April 2025
- 210 Pages
Europe
From €3072EUR$3,500USD£2,673GBP
- Report
- June 2025
- 152 Pages
Latin America
From €3159EUR$3,599USD£2,748GBP
- Report
- August 2024
- 158 Pages
Global
From €1190EUR$1,403USD£1,000GBP
- Report
- September 2022
- 342 Pages
Global
From €4345EUR$4,950USD£3,780GBP
- Report
- January 2025
- 125 Pages
Global
From €3510EUR$3,999USD£3,054GBP
- Report
- October 2025
- 41 Pages
Global
- Report
- January 2023
- 115 Pages
Global
From €5223EUR$5,950USD£4,544GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more